The collection of scientific articles highlights the transformative role of CRISPR technology in genomics and biotechnology, showcasing its diverse applications and potential advancements. In the realm of gene editing in porcine embryos, CRISPR/Cas9 is pivotal for biomedical and agricultural research, with methodologies like SCNT and microinjection being explored. Despite challenges such as off-target effects and mosaicism, refining these techniques could enhance agricultural and biomedical applications.

In diagnostics, a novel CRISPR-Cas12a biosensor integrated with DNAzyme-triggered equilibrium transfer simplifies nucleic acid detection, promising more efficient diagnostic procedures. Meanwhile, CRISPR's role in combating antibiotic-resistant superbugs is underscored by engineering bacteriophages for targeted bacterial eradication, with CRISPR-Cas systems enhancing phage genome manipulation for improved specificity and efficacy.

In plant genomics, CRISPR-mediated prime editing in rice facilitates efficient in situ epitope tagging, broadening the scope for gene function studies and genetic improvements. Similarly, novel cytidine deaminases from the animal kingdom have been harnessed for robust base editing in rice, expanding the targeting scope and minimizing off-target effects.

The EXPERT system advances prime editing by enabling large fragment edits, significantly enhancing editing efficiency without increasing off-target rates. In immunotherapy, CRISPR/Cas9-mediated Bcl11b knockout in CAR-engineered lymphoid progenitors promotes NK-like cell development, offering prolonged anti-leukemic activity.

Additionally, CRISPR-Cas9 genome editing in Fusarium circinatum reveals the Pgs gene's role in pathogenicity, growth, and sporulation, providing insights into the molecular basis of pathogenicity. Collectively, these studies underscore CRISPR's potential to revolutionize biotechnology and genomics, offering innovative solutions across various fields, from agriculture to medicine.